According to studies, which tobacco cessation strategy is considered evidence-based?

Tobacco cessation medications are considered an evidence-based strategy for helping individuals quit smoking. These medications, which may include nicotine replacement therapies (like patches, gum, or lozenges) and prescription medications (such as varenicline and bupropion), have been thoroughly researched and have shown effectiveness in increasing quit rates. Studies demonstrate that these medications work by either providing a controlled dose of nicotine to reduce withdrawal symptoms or impacting brain chemistry to reduce cravings and withdrawal effects.

Evidence-based strategies are grounded in rigorous scientific research and have been validated through clinical trials, making them reliable options for tobacco cessation. The use of tobacco cessation medications is supported by organizations such as the World Health Organization and the Centers for Disease Control and Prevention, emphasizing their importance in comprehensive tobacco control programs. This clear backing from the scientific community distinguishes these medications from other cessation methods, which may lack substantial evidence.